Minfeng Zhang

535 total citations
23 papers, 365 citations indexed

About

Minfeng Zhang is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Minfeng Zhang has authored 23 papers receiving a total of 365 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 7 papers in Cancer Research and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Minfeng Zhang's work include Cancer-related molecular mechanisms research (6 papers), MicroRNA in disease regulation (5 papers) and Hepatocellular Carcinoma Treatment and Prognosis (3 papers). Minfeng Zhang is often cited by papers focused on Cancer-related molecular mechanisms research (6 papers), MicroRNA in disease regulation (5 papers) and Hepatocellular Carcinoma Treatment and Prognosis (3 papers). Minfeng Zhang collaborates with scholars based in China and United States. Minfeng Zhang's co-authors include Xiaodong Liu, Chengjun Sui, Binghua Dai, Jiongjiong Lu, Weifeng Shen, Feng Xu, Jiamei Yang, Cheng Yang, Liye Ma and Liping Lin and has published in prestigious journals such as PLoS ONE, International Journal of Cancer and Medicine.

In The Last Decade

Minfeng Zhang

20 papers receiving 356 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Minfeng Zhang China 11 199 153 56 53 49 23 365
Felix H. Shek Hong Kong 9 347 1.7× 249 1.6× 32 0.6× 43 0.8× 24 0.5× 9 474
Qinghua Qi China 10 103 0.5× 77 0.5× 52 0.9× 22 0.4× 29 0.6× 32 334
Moritz Hess Germany 12 142 0.7× 51 0.3× 32 0.6× 33 0.6× 32 0.7× 29 364
Fei Wu China 10 142 0.7× 95 0.6× 61 1.1× 52 1.0× 37 0.8× 35 327
Chao Guan China 11 181 0.9× 98 0.6× 6 0.1× 39 0.7× 58 1.2× 43 434
Xinwu Guo China 13 285 1.4× 138 0.9× 23 0.4× 35 0.7× 51 1.0× 22 442
Yanmei Zhang China 13 372 1.9× 154 1.0× 8 0.1× 30 0.6× 62 1.3× 37 628
Zhenxiao Wang China 9 119 0.6× 79 0.5× 24 0.4× 13 0.2× 21 0.4× 19 275
Miao Lu China 9 238 1.2× 105 0.7× 43 0.8× 35 0.7× 194 4.0× 27 425
Il‐Chi Chang Taiwan 12 144 0.7× 75 0.5× 32 0.6× 56 1.1× 111 2.3× 18 428

Countries citing papers authored by Minfeng Zhang

Since Specialization
Citations

This map shows the geographic impact of Minfeng Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Minfeng Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Minfeng Zhang more than expected).

Fields of papers citing papers by Minfeng Zhang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Minfeng Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Minfeng Zhang. The network helps show where Minfeng Zhang may publish in the future.

Co-authorship network of co-authors of Minfeng Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Minfeng Zhang. A scholar is included among the top collaborators of Minfeng Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Minfeng Zhang. Minfeng Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Quanlei, et al.. (2024). A novel risk scoring system predicts overall survival of hepatocellular carcinoma using cox proportional hazards machine learning method. Computers in Biology and Medicine. 178. 108663–108663. 4 indexed citations
2.
Shi, Qiang, et al.. (2022). Evaluation of T2-FLAIR combined with ASL on the collateral circulation of acute ischemic stroke. Neurological Sciences. 43(8). 4891–4900. 5 indexed citations
3.
Zhang, Cunzhen, et al.. (2021). TACE plus PD-1 inhibitor (Camrelizumab) treatment for bridging to tumor resection in HCC: Case reports. Clinics and Research in Hepatology and Gastroenterology. 46(1). 101777–101777. 9 indexed citations
4.
Zhang, Gang, Minfeng Zhang, Dongsheng Zhang, et al.. (2021). Changes of the Brain Causal Connectivity Networks in Patients With Long-Term Bilateral Hearing Loss. Frontiers in Neuroscience. 15. 628866–628866. 5 indexed citations
5.
Chen, Xi, Minfeng Zhang, Nan Li, et al.. (2021). Nucleotide variants in hepatitis B virus preS region predict the recurrence of hepatocellular carcinoma. Aging. 13(18). 22256–22275. 3 indexed citations
6.
Zhu, Yumin, Siqi Wang, Minfeng Zhang, et al.. (2020). Integrative analysis of long extracellular RNAs reveals a detection panel of noncoding RNAs for liver cancer. Theranostics. 11(1). 181–193. 45 indexed citations
7.
Liang, Dandan, Minfeng Zhang, Huan Chen, et al.. (2020). The CD68+ macrophages to CD8+ T-cell ratio is associated with clinical outcomes in hepatitis B virus (HBV)-related hepatocellular carcinoma. HPB. 23(7). 1061–1071. 13 indexed citations
8.
Sui, Chengjun, Zhitao Dong, Cheng Yang, et al.. (2019). LncRNA FOXD2‐AS1 as a competitive endogenous RNA against miR‐150‐5p reverses resistance to sorafenib in hepatocellular carcinoma. Journal of Cellular and Molecular Medicine. 23(9). 6024–6033. 34 indexed citations
9.
Ni, Qingqiang, Weifeng Shen, Minfeng Zhang, et al.. (2017). Prognostic analysis of radical resection for intrahepatic cholangiocarcinoma: a retrospective cohort study. Oncotarget. 8(43). 75627–75637. 8 indexed citations
10.
Zhang, Minfeng, Chengjun Sui, Binghua Dai, et al.. (2016). PEG10 is imperative for TGF-β1-induced epithelial-mesenchymal transition in hepatocellular carcinoma. Oncology Reports. 37(1). 510–518. 16 indexed citations
11.
Ni, Qingqiang, Minfeng Zhang, Cheng Yang, et al.. (2016). Congenital hepatic cyst with intracystic hemorrhage. Medicine. 95(42). e5161–e5161.
12.
Sui, Chengjun, Feng Xu, Weifeng Shen, et al.. (2016). MicroRNA-147 suppresses human hepatocellular carcinoma proliferation migration and chemosensitivity by inhibiting HOXC6.. PubMed. 6(12). 2787–2798. 29 indexed citations
13.
Sui, Chengjun, Feng Xu, Weifeng Shen, et al.. (2014). Overexpression of miR-218 inhibits hepatocellular carcinoma cell growth through RET. Tumor Biology. 36(3). 1511–1518. 17 indexed citations
14.
Zhang, Min, Rongrong Zhu, Minfeng Zhang, & Shilong Wang. (2014). Creation of an ethanol-tolerant Saccharomyces cerevisiae strain by 266 nm laser radiation and repetitive cultivation. Journal of Bioscience and Bioengineering. 118(5). 508–513. 12 indexed citations
15.
Huang, Yangqing, Helin Feng, Tong Kan, et al.. (2013). Bevacizumab Attenuates Hepatic Fibrosis in Rats by Inhibiting Activation of Hepatic Stellate Cells. PLoS ONE. 8(8). e73492–e73492. 40 indexed citations
16.
Chang, Wenjun, Liye Ma, Liping Lin, et al.. (2009). Identification of novel hub genes associated with liver metastasis of gastric cancer. International Journal of Cancer. 125(12). 2844–2853. 63 indexed citations
17.
18.
Zhang, Minfeng, et al.. (2004). [Expression of IGF-I and IGF-IR in bladder cancer].. PubMed. 23(6). 707–9. 7 indexed citations
19.
Zhang, Minfeng. (2003). Significance of Transcription Factor E2F-1 Expression in Lung Carcinoma.
20.
Liu, Xiaodong & Minfeng Zhang. (1998). Contemporary climatic change over the qinghai-xizang plateau and its response to the green-house effect. Chinese Geographical Science. 8(4). 289–298. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Felix H. Shek Breakdown of academic impact, for papers by Qinghua Qi Breakdown of academic impact, for papers by Moritz Hess Breakdown of academic impact, for papers by Fei Wu Breakdown of academic impact, for papers by Chao Guan Breakdown of academic impact, for papers by Xinwu Guo Breakdown of academic impact, for papers by Yanmei Zhang Breakdown of academic impact, for papers by Zhenxiao Wang Breakdown of academic impact, for papers by Miao Lu Breakdown of academic impact, for papers by Il‐Chi Chang
Rankless by CCL
2026